BP5mg+TB5mg BB10 Purity 99% - Customization available Chinese factory Pharmaceutical Grade
TDS
15990-43-9
Pharmaceutical Grade
99.87%
HONGKONG
Customization Available
10mg*10vials/box
2026-10-29
Retatrutide,Tirzepatide,GLOW,KLOW80,NAD+,TB500
-
Product Description
-
Seller Information
-
History Price
-
DescriptionECHEMI Editorial ReferenceN-Benzylniacin(BPC) is a colorless to yellowish transparent liquid.Certificates
-
TDS
Basic Info-
Product Name:
N-Benzylniacin
Other Name:1-Benzyl-3-carboxypyridinium hydroxide inner salt;1-benzyl pyridinium-3-carboxylate;N-BENZYLNIACIN;N-BENZYLNICOTINAMIDE;N-Benzyl nicotinate betaine;N-Benzylpyridinium-3-carboxylate;pyridinium,3-carboxy-1-(phenylmethyl)-,hydroxide,innersalt;Pyridinium,3-carboxy-1-(phenylmethyl)-,innersalt
CAS No.:15990-43-9
Molecular Formula:C13H11NO2
InChIKeys:AVWFAACIXBQMBF-UHFFFAOYSA-N
Molecular Weight:213.24
Exact Mass:213.078979
EC Number:240-129-1
TSCA:TSCA listed
DSSTox ID:DTXSID0065989
Color/Form:light yellow
HScode:2933399090
Categories:
Characteristics-
PSA:
44
XLogP3:-2.74
Appearance:light yellow paste
Density:1.09
Refractive Index:1.625
Research-
Class:
Triple agonist — GCGR, GIPR, GLP-1R
Status:Investigational (Phase 3)
Mechanism:Simultaneously activates glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R). Engineered from the native GIP backbone with amino acid substitutions to confer GCGR and GLP-1R activity.
EC50 (Human GCGR):5.79 nM
EC50 (Mouse GIPR):0.191 nM
EC50 (Mouse GLP1R):0.794 nM
EC50 (Mouse GCGR):2.32 nM
EC50 (Human GLP1R):0.775 nM
EC50 (Human GIPR):0.0643 nM
Source:Jastreboff AM, et al. N Engl J Med. 2023;389(6):514-526.DOI
Clinical Development:
References-
ChEMBL:DrugBank:KEGG DRUG:PubChem:Disclaimer:
Retatrutide is an investigational compound not yet approved by FDA or EMA. This listing is for industrial and laboratory research use only. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.
Hazard IdentificationClassification of the substance or mixture
Not classified.
GHS label elements, including precautionary statements
Pictogram(s) No symbol. Signal word No signal word
Hazard statement(s) none
Precautionary statement(s) Prevention none
Response none
Storage none
Disposal none
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
Retatrutide,Tirzepatide,GLOW,KLOW80,NAD+,TB500
-
Location:
Room 11B, Building 0056, No. 81-1 Nonglinxia Road, Yuexiu District, Guangzhou City, Guangdong Province
-
Payment Terms:
100% TT in advance
-
Average lead Time:
7
-
Total Annual Revenue:
$1 million-$2.5 million
-
Total Employees:
5-10
-
Year of Establishment:
2026
-
-
Weekly Price
The chart shows the price trend of the product in the past 12 months.
-
Country Product Purchase Quantity Date Posted Post an enquiry for this product